These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10335045)

  • 1. [Protein glycosylation end products].
    Kropiewnicka EH; Paczek L
    Pol Arch Med Wewn; 1998 Oct; 100(4):350-8. PubMed ID: 10335045
    [No Abstract]   [Full Text] [Related]  

  • 2. Advanced glycation end products in clinical nephrology.
    Kalousová M; Zima T; Tesar V; Stípek S; Sulková S
    Kidney Blood Press Res; 2004; 27(1):18-28. PubMed ID: 14679311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in diabetes - circulating advanced glycation end products, lipid oxidation and vascular disease.
    Dias IH; Griffiths HR
    Ann Clin Biochem; 2014 Mar; 51(Pt 2):125-7. PubMed ID: 24146184
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of advanced glycosylation end products in the pathogenesis of hypertension].
    Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
    Przegl Lek; 2003; 60(9):585-7. PubMed ID: 15065338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carbonyl stress significance in the pathogenesis of dialysis-related amyloidosis].
    Kopeć J
    Przegl Lek; 2003; 60(6):435-7. PubMed ID: 14974183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta 2-microglobulin-related amyloidosis: where do we stand?
    Gejyo F; Arakawa M
    Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
    [No Abstract]   [Full Text] [Related]  

  • 8. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
    Miyata T; Hori O; Zhang J; Yan SD; Ferran L; Iida Y; Schmidt AM
    J Clin Invest; 1996 Sep; 98(5):1088-94. PubMed ID: 8787669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
    Miyata T
    Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxidative stress, hemo-incompatibility and complications of long-term dialysis].
    Morena M; Martin-Mateo M; Cristol JP; Canaud B
    Nephrologie; 2002; 23(5):201-8. PubMed ID: 12227252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of oxidative stress in diabetic vascular complications].
    Inoguchi T; Takayanagi R
    Fukuoka Igaku Zasshi; 2008 Mar; 99(3):47-55. PubMed ID: 18536327
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of oxidative stress in pathogenesis of diabetic microangiopathies].
    Araki E; Nishikawa T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():73-8. PubMed ID: 15999688
    [No Abstract]   [Full Text] [Related]  

  • 13. Advanced glycation end-products and the progress of diabetic vascular complications.
    Jakus V; Rietbrock N
    Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of enzymatic cross-links and non-enzymatic cross-link, advanced glycation end products, as a determinant of bone quality in osteoporosis and diabetes].
    Saito M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():209-13. PubMed ID: 18161108
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycoxidation and diabetic complications: modern lessons and a warning?
    Vlassara H; Uribarri J
    Rev Endocr Metab Disord; 2004 Aug; 5(3):181-8. PubMed ID: 15211089
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidative stress: a key contributor to diabetic cardiomyopathy.
    Khullar M; Al-Shudiefat AA; Ludke A; Binepal G; Singal PK
    Can J Physiol Pharmacol; 2010 Mar; 88(3):233-40. PubMed ID: 20393588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus.
    Valente T; Gella A; Solé M; Durany N; Unzeta M
    J Neurosci Res; 2012 Oct; 90(10):1989-96. PubMed ID: 22714978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis.
    Meerwaldt R; Zeebregts CJ; Navis G; Hillebrands JL; Lefrandt JD; Smit AJ
    Am J Kidney Dis; 2009 Jan; 53(1):138-50. PubMed ID: 19036487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The model Caenorhabditis elegans in diabetes mellitus and Alzheimer's disease.
    Morcos M; Hutter H
    J Alzheimers Dis; 2009; 16(4):897-908. PubMed ID: 19387121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated proteins in diabetes.
    Furth AJ
    Br J Biomed Sci; 1997 Sep; 54(3):192-200. PubMed ID: 9499597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.